Dr. Vandana B. Patravale , fellow of Indian National Science academy(INSA), Indian National academy of engineers(INAE); is currently a Professor of Pharmaceutics at the Institute of Chemical Technology, Mumbai, India. She has more than 30 years of teaching and research experience. She has over 200 refereed publications with over 14650 citations (H index 60, i10 183), 30 granted patents , 20 patents in pipeline and 2 trademark registries. She has published 5 books and 45 book chapters with international publishers. Dr.Patravale has been active in teaching, research and service throughout her career and is listed consecutively in top 2% of World Scientist’s in pharmacy on basis of publications and citations from the time the list is published by Stanford University. Her areas of research include development of nanocarriers with major emphasis on infectious diseases, cancer and neurodegenerative disorders; medical device development, nanodiagnostics and nanovaccines. She was awarded Distinguished Aluminus Award, UDCT(2024),Most Iconic healthcare (Global) leader award 2023,Topmost healthcare leader Global award(education) 2022,Abdul Kalam Technology Innovation National Fellowship 2021,Fellow of Indian Chemical Society 2020, Kukreja Oration award 2020,APTIs Dr. Manjushree Pal Best Pharmaceutical Scientist Award 2019, Shri Amrut Mody distinguished researcher award 2018, OPPI women scientist award 2015, Bill Melinda Gates grant award 2015,Best Pharmaceutical Scientist award 2014, VASVIK award 2013, Veneto nanotech award 2013, APTI best teacher award 2012, Fellowship of Maharashtra Academy of Sciences, 2011and K.H. Garda Distinguished researcher award 2009. She is Convener, APTI Women forum, President-CRS Indian chapter, Vice President-Paediatric Medicine healthcare initiative (PMHI),editor CRS IC and APTI women forum newsletters, Associate editor of Elsevier’s JDDST and on editorial board of many peer reviewed journals. She is actively collaborating with researchers as well as industries within country and abroad and has completed Indo-Swiss, Indo-Ireland, Indo-Japan, Indo-UK projects. She is executing all major grants from Indian Government focusing on product development besides projects from USA and Europe being currently undertaken. She has transferred about 20 + technologies to industry including drug eluting stents being marketed in more than 65 countries.